IBA Announces Share Buyback Program Update
Immediate Release April 18th, 2025
Louvain-la-Neuve, Belgium, April 18th, 2025 - In alignment with article 8:4 of the Royal Decree issued on April 29th, 2019, which implements the Belgian Code on Companies and Associations, Ion Beam Applications SA, commonly known as IBA, has issued a formal announcement concerning its ongoing share buyback program. This program was initially unveiled on March 24th, 2025, and aims to manage the companys obligations tied to long-term incentive plans for its management team and select personnel.
Under the terms of this program, IBA has engaged a financial intermediary with the authority to repurchase a maximum of 650,000 ordinary shares on the companys behalf. This mandate is set to remain effective until December 31st, 2025, with buybacks having commenced on March 25th, 2025.
In the context of this initiative, IBA has recently completed the repurchase of 72,000 shares on the Euronext Brussels exchange within a brief span from April 15th to April 17th, 2025. The details of these transactions are as follows:
| Trade Date | Shares Purchased | Average Price () | Minimum Price () | Maximum Price () | Buyback Amount () |
|---|---|---|---|---|---|
| 15/04/2025 | 50,000 | 10.06 | 10.06 | 10.06 | 503,000.00 |
| 15/04/2025 | 7,000 | 9.98 | 9.95 | 10.10 | 69,867.00 |
| 16/04/2025 | 7,000 | 9.90 | 9.83 | 9.91 | 69,288.80 |
| 17/04/2025 | 8,000 | 9.89 | 9.80 | 9.94 | 79,129.60 |
In total, these transactions amounted to a buyback of 72,000 shares at an average price of 10.02 per share, resulting in a cumulative expenditure of 721,285.40. Notably, a significant portion of this activity involved a large block of 50,000 shares acquired on April 15th, executed precisely at 4:14:20 PM on the central order book of Euronext Brussels (XBRU).
With these recent transactions, IBA has now repurchased a total of 352,017 shares under the current buyback program. The detailed breakdown of treasury shares, which are held directly by IBA SA and indirectly through its associated subsidiary IBA Investments SRL, is as follows:
| Entity | Shares | Voting Rights |
|---|---|---|
| IBA Investments SRL | 51,973 | 103,946 |
| IBA SA | 665,596 | 732,019 |
| Total - Treasury Shares | 717,569 | 835,965 |
| Total - Issued Shares | 30,282,218 | 40,514,366 |
In percentage terms, treasury shares now account for approximately 2.37% of the total shares issued, and represent 2.06% of the overall voting rights.
About IBA
Founded in Louvain-la-Neuve, Belgium, IBA (Ion Beam Applications S.A.) stands as the preeminent leader in the field of particle accelerator technology. The company is recognized as the foremost provider of equipment and services in several pivotal areas, including proton therapy, which is widely regarded as the most sophisticated form of radiation therapy available today. Additionally, IBA is involved in industrial sterilization, radiopharmaceuticals, and dosimetry. With a global workforce of approximately 2,100 dedicated employees, IBA holds the prestigious designation of a certified B Corporation (B Corp), which signifies its adherence to the highest standards of verified social and environmental performance.
IBA is publicly traded on the pan-European stock exchange EURONEXT, and its stock can be tracked under the ticker symbols IBA: Reuters IBAB.BR and Bloomberg IBAB.BB.
For further information about IBA and its initiatives, please visit